United States Antibody Drugs Market Report 2017

August 2017 | 98 pages | ID: U96C8A4F2D0EN
QYResearch

Abstracts

In this report, the United States Antibody Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antibody Drugs in these regions, from 2012 to 2022 (forecast).

United States Antibody Drugs market competition by top manufacturers/players, with Antibody Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Johnson & Johnson
• AbbVie
• Eli Lilly

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Monoclonal Antibodies
• Antibody-Drug Conjugates
• Polyclonal Antibodies

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody Drugs for each application, including

• Central Nervous System (CNS) Disorders
• Cancers
• Autoimmune Disorders
• Cardiovascular Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antibody Drugs Market Report 2017

1 ANTIBODY DRUGS OVERVIEW

1.1 Product Overview and Scope of Antibody Drugs
1.2 Classification of Antibody Drugs by Product Category
  1.2.1 United States Antibody Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antibody Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Monoclonal Antibodies
  1.2.4 Antibody-Drug Conjugates
  1.2.5 Polyclonal Antibodies
1.3 United States Antibody Drugs Market by Application/End Users
  1.3.1 United States Antibody Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Central Nervous System (CNS) Disorders
  1.3.3 Cancers
  1.3.4 Autoimmune Disorders
  1.3.5 Cardiovascular Diseases
1.4 United States Antibody Drugs Market by Region
  1.4.1 United States Antibody Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antibody Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Antibody Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antibody Drugs Status and Prospect (2012-2022)
  1.4.5 New England Antibody Drugs Status and Prospect (2012-2022)
  1.4.6 The South Antibody Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Antibody Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antibody Drugs (2012-2022)
  1.5.1 United States Antibody Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Antibody Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIBODY DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antibody Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antibody Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antibody Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Antibody Drugs Market Competitive Situation and Trends
  2.4.1 United States Antibody Drugs Market Concentration Rate
  2.4.2 United States Antibody Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antibody Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIBODY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antibody Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Antibody Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Antibody Drugs Price by Region (2012-2017)

4 UNITED STATES ANTIBODY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antibody Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antibody Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Antibody Drugs Price by Type (2012-2017)
4.4 United States Antibody Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIBODY DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antibody Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Antibody Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIBODY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antibody Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen
  6.2.2 Antibody Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb
  6.3.2 Antibody Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 F. Hoffmann-La Roche
  6.4.2 Antibody Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
  6.5.2 Antibody Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AbbVie
  6.6.2 Antibody Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Eli Lilly
  6.7.2 Antibody Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Eli Lilly Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ANTIBODY DRUGS MANUFACTURING COST ANALYSIS

7.1 Antibody Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibody Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antibody Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibody Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIBODY DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antibody Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antibody Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Antibody Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Antibody Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antibody Drugs
Figure United States Antibody Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Antibody Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Antibody-Drug Conjugates Product Picture
Figure Polyclonal Antibodies Product Picture
Figure United States Antibody Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Antibody Drugs by Application in 2016
Figure Central Nervous System (CNS) Disorders Examples
Table Key Downstream Customer in Central Nervous System (CNS) Disorders
Figure Cancers Examples
Table Key Downstream Customer in Cancers
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure United States Antibody Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Antibody Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Antibody Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody Drugs Sales Share by Players/Suppliers
Figure 2017 United States Antibody Drugs Sales Share by Players/Suppliers
Figure United States Antibody Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antibody Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antibody Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Antibody Drugs Revenue Share by Players/Suppliers
Table United States Market Antibody Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Antibody Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Antibody Drugs Market Share of Top 3 Players/Suppliers
Figure United States Antibody Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antibody Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antibody Drugs Product Category
Table United States Antibody Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Antibody Drugs Sales Share by Region (2012-2017)
Figure United States Antibody Drugs Sales Share by Region (2012-2017)
Figure United States Antibody Drugs Sales Market Share by Region in 2016
Table United States Antibody Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antibody Drugs Revenue Share by Region (2012-2017)
Figure United States Antibody Drugs Revenue Market Share by Region (2012-2017)
Figure United States Antibody Drugs Revenue Market Share by Region in 2016
Table United States Antibody Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Antibody Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Antibody Drugs Sales Share by Type (2012-2017)
Figure United States Antibody Drugs Sales Share by Type (2012-2017)
Figure United States Antibody Drugs Sales Market Share by Type in 2016
Table United States Antibody Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antibody Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Drugs by Type (2012-2017)
Figure Revenue Market Share of Antibody Drugs by Type in 2016
Table United States Antibody Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Antibody Drugs Sales Growth Rate by Type (2012-2017)
Table United States Antibody Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Antibody Drugs Sales Market Share by Application (2012-2017)
Figure United States Antibody Drugs Sales Market Share by Application (2012-2017)
Figure United States Antibody Drugs Sales Market Share by Application in 2016
Table United States Antibody Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Antibody Drugs Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Antibody Drugs Sales Growth Rate (2012-2017)
Figure Novartis Antibody Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Antibody Drugs Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Antibody Drugs Sales Growth Rate (2012-2017)
Figure Amgen Antibody Drugs Sales Market Share in United States (2012-2017)
Figure Amgen Antibody Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Antibody Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Antibody Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Antibody Drugs Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Antibody Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Antibody Drugs Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Antibody Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Antibody Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Antibody Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Antibody Drugs Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Antibody Drugs Sales Growth Rate (2012-2017)
Figure AbbVie Antibody Drugs Sales Market Share in United States (2012-2017)
Figure AbbVie Antibody Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Antibody Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Antibody Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Antibody Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drugs
Figure Manufacturing Process Analysis of Antibody Drugs
Figure Antibody Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drugs Major Players/Suppliers in 2016
Table Major Buyers of Antibody Drugs
Table Distributors/Traders List
Figure United States Antibody Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antibody Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antibody Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Antibody Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antibody Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antibody Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Antibody Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antibody Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antibody Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Antibody Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Antibody Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources